Oslo, Norway, 24 October 2024

Vistin Pharma ASA will release its third quarter and YTD 2024 results on Thursday 31st of October 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Thursday 31st of October at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The third quarter conference call will be available via web and audio through the following access points:

Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

Webcast: https://edge.media-server.com/mmc/p/vbrzzjjk

Telephone conference (online registration): https://register.vevent.com/register/BI809b345192f14b6882c8bda7de2220b6

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

[email protected]

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act